Tesofensine – 0.25 mg Capsules (60 Count)
Tesofensine – 0.25 mg Capsules (60 Count) Tesofensine is an investigational oral treatment being studied for obesity. It functions as a triple monoamine reuptake inhibitor, affecting serotonin, norepinephrine, and dopamine to help manage appetite. Studies have explored the effects of different amounts of tesofensine on weight loss.
Research Use Only Disclaimer
FOR RESEARCH USE ONLY This product is not intended for human or animal use.Not for medical, diagnostic, therapeutic, neurological, metabolic, or consumption purposes.No dosage, administration, or biological outcome claims are made or implied.Use is restricted to qualified laboratory research environments only.
❓Frequently Asked Questions
Is Tesofensine approved for medical or dietary use?
No. This compound is supplied strictly for laboratory research purposes.
Does this product include a Certificate of Analysis (COA)?
Yes. Every batch includes a third-party verified COA.
Why is this compound provided in capsule format?
The encapsulated format supports research involving formulation consistency, capsule integrity, and stability evaluation, not consumption.
Can this compound be used in humans or animals?
No. It is not approved for use in living systems.
How is this product classified?
It is classified solely as a research compound, not a drug, supplement, or therapeutic agent.